News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
167,770 Results
Type
Article (7810)
Company Profile (10)
Press Release (159950)
Section
Business (57554)
Career Advice (516)
Deals (10291)
Drug Delivery (21)
Drug Development (24342)
Employer Resources (31)
FDA (4181)
Job Trends (4368)
News (94194)
Policy (7350)
Tag
Academia (467)
Africa (192)
Allergies (18)
Alliances (6943)
Alzheimer's disease (330)
Approvals (4174)
Arizona (22)
Asia (10231)
Australia (1701)
Bankruptcy (103)
Best Places to Work (3767)
Biosimilars (21)
Breast cancer (35)
C2C Services and Suppliers (15364)
California (712)
Canada (320)
Cancer (291)
Career advice (421)
Cell therapy (46)
China (61)
Clinical research (20230)
Collaboration (48)
Colorado (26)
Compensation (25)
Connecticut (42)
COVID-19 (652)
Data (273)
Delaware (30)
Diabetes (40)
Diagnostics (1613)
Earnings (42891)
Employer resources (27)
Europe (24321)
Events (26215)
Executive appointments (40)
FDA (4281)
Florida (91)
Funding (58)
Gene therapy (32)
Georgia (23)
GLP-1 (213)
Government (1125)
Healthcare (5155)
Hotbed/Location (114657)
Illinois (70)
Indiana (56)
Infectious disease (668)
Inflammatory bowel disease (36)
Interviews (92)
IPO (6521)
Japan (19)
Job creations (708)
Job search strategy (379)
Kansas (19)
Layoffs (112)
Legal (1358)
Lung cancer (63)
Manufacturing (33)
Maryland (92)
Massachusetts (547)
Medical device (3487)
Medtech (3487)
Mergers & acquisitions (3742)
Metabolic disorders (131)
Michigan (27)
Minnesota (53)
Neuroscience (396)
New Jersey (233)
New York (256)
NextGen Class of 2024 (1398)
Non-profit (1030)
North Carolina (165)
Northern California (336)
Obesity (82)
Ohio (31)
Opinion (39)
Pennsylvania (206)
People (5316)
Phase I (5193)
Phase II (8516)
Phase III (7965)
Pipeline (105)
Postmarket research (946)
Preclinical (1645)
Radiopharmaceuticals (75)
Rare diseases (34)
Real estate (890)
Regulatory (5170)
Research institute (428)
Resumes & cover letters (86)
South America (284)
Southern California (280)
Startups (579)
Texas (101)
United States (2969)
Utah (25)
Vaccines (141)
Virginia (18)
Washington State (85)
Weight loss (65)
Date
Last 7 days (341)
Last 30 days (1195)
Last 365 days (12505)
2024 (9376)
2023 (12586)
2022 (16375)
2021 (16028)
2020 (14214)
2019 (12463)
2018 (9249)
2017 (8432)
2016 (7674)
2015 (8968)
2014 (6474)
2013 (5020)
2012 (5583)
2011 (6090)
2010 (5121)
167,770 Results for "7".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P
Elicio Therapeutics, Inc. announced new preliminary data from the ongoing AMPLIFY-7P Phase 1a study of its off-the-shelf investigational therapeutic cancer vaccine candidate, ELI-002 7P.
June 27, 2024
·
6 min read
Lone Star Bio
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
7 Hills Pharma Inc., a clinical-stage pharma company leveraging a novel mechanism of action to safely enhance the effectiveness of cancer immunotherapies, was awarded $4.7 million from the Cancer Prevention and Research Institute of Texas to support its cell/gene therapy development program.
June 3, 2024
·
5 min read
Dioseve Completes Funding Round, Raising a Total of 7 Million USD
Dioseve Inc., aiming to develop assisted reproductive technology using oocytes derived from iPS cells, has raised 7 million USD.
June 27, 2024
·
2 min read
Press Releases
QurAlis Announces Expansion of its Selective Kv7.2/7.3 Ion Channel Opener, QRL-101, Into Epilepsy
September 19, 2024
·
4 min read
MicuRx To Present New Data At 7th World Bronchiectasis Conference
Shanghai MicuRx Pharmaceutical Co., Ltd. announced 3 new studies will be presented at the 7th World Bronchiectasis Conference, taking place from July 4 - 6, 2024 in Dundee, Scotland.
June 19, 2024
·
2 min read
Deals
Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals for $7.25 to $7.75 Per Share in Cash
Future Pak LLC (“Future Pak”) today announced that it has submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals, Inc. (“Vanda”) (NASDAQ: VNDA), and confirms that its most recent proposal to acquire Vanda for cash consideration of $7.25 to $7.75 per share remains open for Vanda and its Board of Directors to consider.
April 17, 2024
·
2 min read
Biotech Bay
Raydiant Oximetry Oversubscribes Series A $7.5 Million Extension Round
Raydiant Oximetry, Inc., a clinical-stage medical device company that develops medical technologies to improve outcomes for mothers and babies during childbirth, announced that it has oversubscribed a $7.5 million Series A3 extension round.
June 4, 2024
·
3 min read
Press Releases
Factor 7 Medical Acquisition Ignites Bold Growth Strategy
September 17, 2024
·
2 min read
Pancreatic Cancer Market Size to Rise at USD 7.4 Billion by 2032
The pancreatic cancer market size grew to USD 2.05 billion in 2022 and is estimated to hit approximately USD 7.4 billion by 2032, with a CAGR of 13.7% for the period of 2023 – 2032.
April 22, 2024
·
12 min read
Genetown
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”) today announced preliminary data from the ongoing AMPLIFY-7P Phase 1a study of its off-the-shelf investigational therapeutic cancer vaccine candidate, ELI-002 7P, in a poster presentation at the American Society of Clinical Oncology (“ASCO”) Annual Meeting.
May 23, 2024
·
9 min read
1 of 16,777
Next